This website does readability filtering of other pages. All styles, scripts, forms and ads are stripped. If you want your website excluded or have other feedback, use this form.

Supportive therapy in haematology (eBook, 1985) [WorldCat.org]

Home WorldCat Home About WorldCat Help Search Search for Library Items Search for Lists Search for Contacts Search for a Library Create lists, bibliographies and reviews: or Your list has reached the maximum number of items. Please create a new list with a new name; move some items to a new or existing list; or delete some items. Your request to send this item has been completed.

Add a review Would you also like to submit a review for this item? Cancel Your list has reached the maximum number of items. Please create a new list with a new name; move some items to a new or existing list; or delete some items. You already recently rated this item. Your rating has been recorded Preview this item
Checking...

Supportive therapy in haematology

Author:P C Das; C Th Smit Sibinga; M R Halie Publisher:Boston, MA : Springer US, 1985. Edition/Format:  eBook : Document : EnglishView all editions and formats Summary:As appropriately outlined in the first chapter in cells was pioneered in Holland by Van Loghem and part II in this book, the history of contemporary Van Rood, and it led eventually to the discovery of blood transfusion is only three-quarters of a cen the HLA system and its subsequent explosive de tury old. On the surface, there is not much left in velopment. In biochemistry, the work on the ABO common between an arm to arm blood transfer and MN blood group substances has provided carried out as an heroic measure in the twenties, pointers to general features of the biosynthesis and when patient or donor had to be weighed in order role of glycolipids and glycoproteins in the cell for the physician to decide when to stop, and blood membrane, and the identification of serological component therapy of today, when several patients specificities associated with specific oligo sac can benefit from appropriately measured and stan chari des has proven for the first time how gene dardized amounts of various purified blood frac products that are not proteins can exhibit Men tions. Yet, the basic principles of blood transfusion delian inheritance.  Read more... Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects More like this

Find a copy online

Links to this item

SpringerLink

Add library to Favorites

Please choose whether or not you want other users to be able to see on your profile that this library is a favorite of yours.

Save   

Find a copy in the library

Finding libraries that hold this item...

Details

Genre/Form:Electronic books Additional Physical Format:Print version: Material Type:Document, Internet resource Document Type:Internet Resource, Computer File All Authors / Contributors:P C Das; C Th Smit Sibinga; M R Halie ISBN:9781461325772 1461325773 OCLC Number:852789538 Description:1 online resource (422 pages) Contents:One: Pathophysiology --
1. Role of cell culture in the management of haematological diseases --
2. Oxygen transport to the tissue and blood viscosity --
3. Infection prevention in neutropenic patients --
4. Apheresis units: designs and future applications --
5. Platelets for transfusion: collection, storage and clinical efficacy --
6. Leukapheresis: clinical experience and post-transfusion control --
7. Plasma proteins for therapeutic use: past, present and future --
8. Clinical significance of tissue antigens --
9. Clinical significance of red cell blood groups --
10. The crossmatch: how much is enough? --
11. Isoimmunisation in pregnancy: diagnosis, treatment and prevention --
12. Immune plasma for immunoglobulin --
Two: Clinical Practice --
1. Blood and blood components: uses and abuses --
2. Massive transfusion and its effects in clinical practice --
3. Diagnosis of bleeding disorders --
4. Treatment of the haemophilias --
5. Advances in the treatment of thrombocytopenia --
6. Red cell therapy --
7. Blood transfusion in sickle cell disease --
8. Supportive care in leukemia treatment --
9. Immunosuppression and oncology --
10. Use of immunoglobulins --
11. Bone marrow transplantation (BMT) --
12. Transfusion support and obstetrical haemorrhage --
13. Cardiac operations and transfusion requirements --
14. Supportive therapy for liver transplantation --
15. Supportive therapy in the new born --
16. Therapeutic plasma exchange --
17. Transfusion related morbidity and mortality in the intensive care facility --
18. Infections transmitted by blood transfusion --
Three: Future Trends --
1. Hepatitis B in pregnancy --
2. Interferons: past, present and future --
3. The use of antibody in the malignant blood diseases --
4. Therapeutic approaches to abnormalities of blood rheology in vascular disease --
5. Can we support comprehensive home care for haemophiliacs? --
6. Transfusion support in a community disaster --
7. Comprehensive haemotherapy program for developing countries --
8. Artificial blood substitutes. Responsibility:edited by P.C. Das, C. Th. Smit Sibinga, M.R. Halie.

Abstract:

As appropriately outlined in the first chapter in cells was pioneered in Holland by Van Loghem and part II in this book, the history of contemporary Van Rood, and it led eventually to the discovery of blood transfusion is only three-quarters of a cen the HLA system and its subsequent explosive de tury old. On the surface, there is not much left in velopment. In biochemistry, the work on the ABO common between an arm to arm blood transfer and MN blood group substances has provided carried out as an heroic measure in the twenties, pointers to general features of the biosynthesis and when patient or donor had to be weighed in order role of glycolipids and glycoproteins in the cell for the physician to decide when to stop, and blood membrane, and the identification of serological component therapy of today, when several patients specificities associated with specific oligo sac can benefit from appropriately measured and stan chari des has proven for the first time how gene dardized amounts of various purified blood frac products that are not proteins can exhibit Men tions. Yet, the basic principles of blood transfusion delian inheritance.

Reviews

User-contributed reviews Add a review and share your thoughts with other readers. Be the first. Add a review and share your thoughts with other readers. Be the first.

Tags

Add tags for "Supportive therapy in haematology". Be the first.

Similar Items

Related Subjects:(2)

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data

More info about Linked Data

Primary Entity

<[www.worldcat.org]> # Supportive therapy in haematology
    a schema:MediaObject, schema:Book, schema:CreativeWork ;
   library:oclcnum "852789538" ;
   library:placeOfPublication <[experiment.worldcat.org]> ; # Boston, MA
   library:placeOfPublication <[id.loc.gov]> ;
   schema:about <[dewey.info]> ;
   schema:about <[id.worldcat.org]> ; # Hematology
   schema:about <[id.worldcat.org]> ; # Medicine
   schema:bookFormat schema:EBook ;
   schema:contributor <[viaf.org]> ; # M. R. Halie
   schema:contributor <[viaf.org]> ; # C Th Smit Sibinga
   schema:creator <[viaf.org]> ; # P. C. Das
   schema:datePublished "1985" ;
   schema:description "As appropriately outlined in the first chapter in cells was pioneered in Holland by Van Loghem and part II in this book, the history of contemporary Van Rood, and it led eventually to the discovery of blood transfusion is only three-quarters of a cen the HLA system and its subsequent explosive de tury old. On the surface, there is not much left in velopment. In biochemistry, the work on the ABO common between an arm to arm blood transfer and MN blood group substances has provided carried out as an heroic measure in the twenties, pointers to general features of the biosynthesis and when patient or donor had to be weighed in order role of glycolipids and glycoproteins in the cell for the physician to decide when to stop, and blood membrane, and the identification of serological component therapy of today, when several patients specificities associated with specific oligo sac can benefit from appropriately measured and stan chari des has proven for the first time how gene dardized amounts of various purified blood frac products that are not proteins can exhibit Men tions. Yet, the basic principles of blood transfusion delian inheritance."@en ;
   schema:description "One: Pathophysiology -- 1. Role of cell culture in the management of haematological diseases -- 2. Oxygen transport to the tissue and blood viscosity -- 3. Infection prevention in neutropenic patients -- 4. Apheresis units: designs and future applications -- 5. Platelets for transfusion: collection, storage and clinical efficacy -- 6. Leukapheresis: clinical experience and post-transfusion control -- 7. Plasma proteins for therapeutic use: past, present and future -- 8. Clinical significance of tissue antigens -- 9. Clinical significance of red cell blood groups -- 10. The crossmatch: how much is enough? -- 11. Isoimmunisation in pregnancy: diagnosis, treatment and prevention -- 12. Immune plasma for immunoglobulin -- Two: Clinical Practice -- 1. Blood and blood components: uses and abuses -- 2. Massive transfusion and its effects in clinical practice -- 3. Diagnosis of bleeding disorders -- 4. Treatment of the haemophilias -- 5. Advances in the treatment of thrombocytopenia -- 6. Red cell therapy -- 7. Blood transfusion in sickle cell disease -- 8. Supportive care in leukemia treatment -- 9. Immunosuppression and oncology -- 10. Use of immunoglobulins -- 11. Bone marrow transplantation (BMT) -- 12. Transfusion support and obstetrical haemorrhage -- 13. Cardiac operations and transfusion requirements -- 14. Supportive therapy for liver transplantation -- 15. Supportive therapy in the new born -- 16. Therapeutic plasma exchange -- 17. Transfusion related morbidity and mortality in the intensive care facility -- 18. Infections transmitted by blood transfusion -- Three: Future Trends -- 1. Hepatitis B in pregnancy -- 2. Interferons: past, present and future -- 3. The use of antibody in the malignant blood diseases -- 4. Therapeutic approaches to abnormalities of blood rheology in vascular disease -- 5. Can we support comprehensive home care for haemophiliacs? -- 6. Transfusion support in a community disaster -- 7. Comprehensive haemotherapy program for developing countries -- 8. Artificial blood substitutes."@en ;
   schema:exampleOfWork <[worldcat.org]> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isSimilarTo <[worldcat.org]> ;
   schema:name "Supportive therapy in haematology"@en ;
   schema:productID "852789538" ;
   schema:publication <[www.worldcat.org]> ;
   schema:publisher <[experiment.worldcat.org]> ; # Springer US
   schema:url <[dx.doi.org]> ;
   schema:workExample <[dx.doi.org]> ;
   schema:workExample <[worldcat.org]> ;
   wdrs:describedby <[www.worldcat.org]> ;
    .


Related Entities

<[dewey.info]>
    a schema:Intangible ;
    .

<[dx.doi.org]>
    a schema:IndividualProduct ;
    .

<[experiment.worldcat.org]> # Springer US
    a bgn:Agent ;
   schema:name "Springer US" ;
    .

<[experiment.worldcat.org]> # Boston, MA
    a schema:Place ;
   schema:name "Boston, MA" ;
    .

<[id.loc.gov]>
    a schema:Place ;
   dcterms:identifier "mau" ;
    .

<[id.worldcat.org]> # Medicine
    a schema:Intangible ;
   schema:name "Medicine"@en ;
    .

<[id.worldcat.org]> # Hematology
    a schema:Intangible ;
   schema:name "Hematology"@en ;
    .

<[viaf.org]> # M. R. Halie
    a schema:Person ;
   schema:familyName "Halie" ;
   schema:givenName "M. R." ;
   schema:name "M. R. Halie" ;
    .

<[viaf.org]> # C Th Smit Sibinga
    a schema:Person ;
   schema:familyName "Sibinga" ;
   schema:givenName "C. Th. Smit" ;
   schema:name "C Th Smit Sibinga" ;
    .

<[viaf.org]> # P. C. Das
    a schema:Person ;
   schema:familyName "Das" ;
   schema:givenName "P. C." ;
   schema:name "P. C. Das" ;
    .

<[worldcat.org]>
    a schema:CreativeWork ;
   schema:description "Print version:" ;
   schema:isSimilarTo <[www.worldcat.org]> ; # Supportive therapy in haematology
    .

<[worldcat.org]>
    a schema:ProductModel ;
   schema:isbn "1461325773" ;
   schema:isbn "9781461325772" ;
    .

<[www.worldcat.org]>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <[www.worldcat.org]> ; # Supportive therapy in haematology
   schema:dateModified "2018-11-09" ;
   void:inDataset <[purl.oclc.org]> ;
    .

<[www.worldcat.org]>
    a schema:PublicationEvent ;
   schema:location <[experiment.worldcat.org]> ; # Boston, MA
   schema:organizer <[experiment.worldcat.org]> ; # Springer US
   schema:startDate "1985" ;
    .


Content-negotiable representations

852789538 9781461325772 1461325773 Supportive therapy in haematology/P C Das; C Th Smit Sibinga; M R Halie; Boston, MA : Springer US, 1985. 21274 book_digital Languages: Česky  |  Deutsch  |  English  |  Español  |  Français  |  Italiano  |  Nederlands  |  Português  |  ภาษาไทย  |  한국어  |  日本語  |  中文(繁體)  |  中文(简体) You: Sign In | Register | My WorldCat | My Lists | My Watchlist | My Reviews | My Tags | My Saved Searches WorldCat: Home | About | Help | Search Legal: Copyright © 2001-2018 OCLC. All rights reserved. | Privacy Policy | Terms and Conditions

WorldCat is the world's largest library catalog, helping you find library materials online. Learn more ››

Follow WorldCat:

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.